SC TO-T/A 1 0001.txt AMEND NO.7 TO TENDER OFFER STATEMENT =============================================================================== SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ----------- Amendment No. 7 to SCHEDULE TO Tender Offer Statement under Section 14(d)(1) or 13(e)(1) of the Securities Exchange Act of 1934 and Amendment No. 7 to SCHEDULE 13D under the Securities Exchange Act of 1934 ----------- Sybron Chemicals Inc. (Name of Subject Company (Issuer)) Project Toledo Acquisition Corp. Bayer Corporation Bayer Aktiengesellschaft (Names of Filing Persons (Offerors)) ----------- COMMON STOCK, PAR VALUE $.01 PER SHARE (Title of Class of Securities) ----------- 870903101 (Cusip Number of Class of Securities) ----------- Bruce A. Mackintosh, Esq. Bayer Corporation 100 Bayer Road Pittsburgh, PA 15205-9741 Telephone: (412) 777-2000 (Name, address and telephone number of person authorized to receive notices and communications on behalf of filing persons) Copy to: Daniel P. Cunningham, Esq. Cravath, Swaine & Moore 825 Eighth Avenue New York, New York 10019-7475 Telephone: (212) 474-1000 --------------------------- October 26, 2000 --------------------------- 2 [ ] Check the box if the filing relates to preliminary communications made before the commencement of a tender offer. Check the appropriate boxes below to designate any transactions to which the statement relates: [X] third-party tender offer subject to Rule 14d-1. [ ] issuer tender offer subject to Rule 13e-4. [ ] going-private transaction subject to Rule 13e-3. [X] amendment to Schedule 13D under Rule 13d-2. Check the following box if the filing is a final amendment reporting the results of the tender offer: [X] =============================================================================== 3 Project Toledo Acquisition Corp., a Delaware corporation (the "Purchaser"), Bayer Corporation, an Indiana corporation ("Parent"), and Bayer Aktiengesellschaft, a company organized under the laws of the Federal Republic of Germany ("Bayer AG"), hereby amend and supplement their Tender Offer Statement on Schedule TO (the "Schedule TO") and their Schedule 13D, in each case, originally filed on September 8, 2000. The Schedule TO relates to the offer by the Purchaser to purchase all outstanding shares of common stock, par value $.01 per share (the "Shares"), of Sybron Chemicals Inc., a Delaware corporation (the "Company"), together with the associated rights (the "Rights") to purchase Series A Junior Participating Preferred Stock pursuant to the Rights Agreement, at $35 per Share, net to the seller in cash, without interest thereon, upon the terms and subject to the conditions set forth in the Offer to Purchase dated September 8, 2000 (the "Offer to Purchase"), and in the related Letter of Transmittal. Capitalized terms used, and not otherwise defined, herein have the meanings assigned thereto in the Offer to Purchase. Item 11. Additional Information. Item 11 to the Schedule TO is hereby amended and supplemented by the following: On October 23, 2000, the Purchaser accepted for payment, and paid for, 5,660,116 Shares. On October 26, 2000, the Purchaser accepted for payment an additional 47,818 Shares delivered pursuant to Notices of Guaranteed Delivery. 4 SIGNATURES After due inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. PROJECT TOLEDO ACQUISITION CORP., By: /s/ John L. Williams -------------------------------------- Name: Dr. John L. Williams Title: President BAYER CORPORATION, By: /s/ E.L. Foote, Jr. -------------------------------------- Name: E.L. Foote, Jr. Title: Executive Vice President BAYER AKTIENGESELLSCHAFT, By: /s/ Roland Hartwig -------------------------------------- Name: Dr. Roland Hartwig Title: General Counsel Dated: October 26, 2000